FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/07/2023
Voltar para busca
Dado oficial do USPTO
QIAREACH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
03/07/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9
Data de depósito
16/03/2021
Data de registro
07/03/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/03/2023
Última transação
07/03/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
DE
Examinador
HACK, ANDREA R
Unidade examinadora
L80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Qiagen GmbH
Representantes
Randolph E. Digges, III Rankin, Hill & Clark LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical and biochemical preparations for use in industry and research; biotechnological products for use in industry and research usediagnostic reagentsbufferspeptides and antigens; chemical and biochemical preparations for non-medical use; biotechnological products for non-medical purposesdiagnostic reagentsbufferspeptides and antigens; chemicalbiochemical and biotechnological products for use in in-vitro diagnostic for non-medical purposeschemically treated lateral flow test strips for non-medical purposesfor detection of pathogens and viruses and bacteriadiagnostic reagentsbufferspeptides and antigens; chemicalbiochemical and biotechnological products for use in scientific and laboratory researchdiagnostic reagentsbufferspeptidesantigens and chemically treated lateral flow test strips for detection of pathogensvirusesbacteria; chemicalbiochemical and biotechnological preparations for use in in-vitro diagnostic for scientific research or laboratory use; reagent kits comprising chemicalbiochemical and biotechnological preparations for industrial and scientific purposes; reagent kits comprising chemicalbiochemical and biotechnological preparations for use in in-vitro diagnostic for non-medical purposes; chemicalbiochemical and biotechnological test kits comprised of diagnostic reagentsbufferspeptides and antigens for in-vitro detection of pathogensviruses and bacteria for laboratory or research use; biochemicalsantibodies for in-vitro scientific or research use; chemicalbiochemical and biotechnological kits comprising antibodies for in-vitro detection of pathogensviruses and bacteria for scientific or research use; chemicalbiochemical and biotechnological products for medical and pharmaceutical researchchemically treated lateral flow test strips for detection of pathogensviruses and bacteria
Classe 5
Chemicalbiochemical and biotechnological preparations for medical and veterinary purposespreparations for treating diseases or conditions caused by pathogensviruses and bacteria; chemicalbiochemical and biotechnological preparations for human in-vitro medical diagnostic purposesfor diagnosing diseases or conditions caused by pathogensviruses and bacteria; chemicalbiochemical and biotechnological reagents and preparations for human in-vitro medical diagnostic purposes; chemicalbiochemical and biotechnological products for human in-vitro medical diagnostic purposeschemically treated lateral flow test strips for detection of pathogensviruses and bacteria; kits comprising chemicalbiochemical and biotechnological preparations for human in-vitro medical diagnostic purposes; chemicalbiochemical and biotechnological preparations for medical and pharmaceutical purposes; diagnostic kits comprising chemical preparations for human in-vitro diagnostic for medical or pharmaceutical purposesfor diagnosing diseases or conditions caused by pathogensviruses and bacteria; diagnostic kits comprising chemicalbiochemical and biotechnological preparations for human in-vitro diagnostic for detection of pathogensviruses and bacteria for medical or pharmaceutical purposes; biochemicalsantibodies for use in human in vitro medical diagnostic use; chemicalbiochemical and biotechnological kits for human in-vitro diagnostic use comprising antibodies for in-vitro detection of pathogensviruses and bacteria
Classe 9
Scientific apparatusesinstruments and devices for researchdevelopment and examination purposeschromatography deviceslaboratory robotsrobotic workstations being laboratory robotsoptoelectronic devices for handling and analyzing nucleic acidsproteinsenzymeschemicals; structural and replacement parts for chromatography deviceslaboratory robotsrobotic workstations being laboratory robotsoptoelectronic devices for handling and analyzing nucleic acidsproteinsenzymeschemicals; downloadable software for use in scientific and medical researchsoftware for detectingidentifyingquantifying and specifying pathogensviruses and bacteria; scientific apparatusesinstruments and deviceschromatography deviceslaboratory robotsrobotic workstations being laboratory robotsoptoelectronic devices for handling and analyzing nucleic acidsproteinsenzymeschemicals; downloadable software for detection of pathogensviruses and bacteriain particular detection by specific antibodies
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/06/2023
FIMP
FINAL DISPOSITION PROCESSED
09/06/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/06/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
20/03/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/03/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
07/03/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/03/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/03/2023
GPNX
NOTIFICATION PROCESSED BY IB
21/12/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/12/2022
PUBO
PUBLISHED FOR OPPOSITION
20/12/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
30/11/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
30/11/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
30/11/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/11/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
11/11/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/11/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
11/11/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/11/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
19/05/2022
GNFR
FINAL REFUSAL E-MAILED
19/05/2022
CNFR
FINAL REFUSAL WRITTEN
19/05/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/05/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/05/2022
RFNT
REFUSAL PROCESSED BY IB
06/12/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/11/2021
RFRR
REFUSAL PROCESSED BY MPU
18/11/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
22/10/2021
CNRT
NON-FINAL ACTION WRITTEN
21/10/2021
DOCK
ASSIGNED TO EXAMINER
18/10/2021
MAFR
APPLICATION FILING RECEIPT MAILED
12/10/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/10/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
30/09/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace QIAREACH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.